Gender identity refers to one’s personal sense of gender and includes identifying as cisgender (ie, a gender identity that aligns with the sex assigned at birth), transgender (ie, a gender identity that does not align with the sex assigned at birth), and gender nonconforming (GNC) (ie, a gender identity that does not follow others’ ideas about how a person should look or act based on the sex assigned at birth). There has been increasing national focus on examining cancer risks of transgender and gender-nonconforming (TGNC) patients1 and, although prior research has examined skin cancer prevalence among sexual minority populations,2 this study is the first, to our knowledge, to evaluate skin cancer history by gender identity.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Singer S, Tkachenko E, Hartman RI, Mostaghimi A. Gender Identity and Lifetime Prevalence of Skin Cancer in the United States. JAMA Dermatol. Published online February 12, 2020. doi:10.1001/jamadermatol.2019.4197
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: